These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 24552351

  • 1. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.
    Slavova-Azmanova NS, Kucera N, Louw A, Satiaputra J, Handoko A, Singer P, Stone L, McCarthy DJ, Klinken SP, Hibbs ML, Ingley E.
    Biochem J; 2014 May 01; 459(3):455-66. PubMed ID: 24552351
    [Abstract] [Full Text] [Related]

  • 2. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
    Tilbrook PA, Palmer GA, Bittorf T, McCarthy DJ, Wright MJ, Sarna MK, Linnekin D, Cull VS, Williams JH, Ingley E, Schneider-Mergener J, Krystal G, Klinken SP.
    Cancer Res; 2001 Mar 15; 61(6):2453-8. PubMed ID: 11289114
    [Abstract] [Full Text] [Related]

  • 3. Gain-of-function Lyn induces anemia: appropriate Lyn activity is essential for normal erythropoiesis and Epo receptor signaling.
    Slavova-Azmanova NS, Kucera N, Satiaputra J, Stone L, Magno A, Maxwell MJ, Quilici C, Erber W, Klinken SP, Hibbs ML, Ingley E.
    Blood; 2013 Jul 11; 122(2):262-71. PubMed ID: 23692855
    [Abstract] [Full Text] [Related]

  • 4. Csk-binding protein controls red blood cell development via regulation of Lyn tyrosine kinase activity.
    Plani-Lam JH, Slavova-Azmanova NS, Kucera N, Louw A, Satiaputra J, Singer P, Lam KP, Hibbs ML, Ingley E.
    Exp Hematol; 2017 Feb 11; 46():70-82.e10. PubMed ID: 27751872
    [Abstract] [Full Text] [Related]

  • 5. Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility.
    Subramanian A, Hegde S, Correll PH, Paulson RF.
    Leuk Res; 2006 Sep 11; 30(9):1141-9. PubMed ID: 16527351
    [Abstract] [Full Text] [Related]

  • 6. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
    Shi J, Yuan B, Hu W, Lodish H.
    Exp Hematol; 2016 Nov 11; 44(11):1044-1058.e5. PubMed ID: 27473563
    [Abstract] [Full Text] [Related]

  • 7. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W, Zhang J, Lodish HF.
    Blood; 2005 Jun 15; 105(12):4604-12. PubMed ID: 15705783
    [Abstract] [Full Text] [Related]

  • 8. A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution.
    Halupa A, Bailey ML, Huang K, Iscove NN, Levy DE, Barber DL.
    Blood; 2005 Jan 15; 105(2):552-61. PubMed ID: 15213094
    [Abstract] [Full Text] [Related]

  • 9. CD45 tyrosine phosphatase inhibits erythroid differentiation of umbilical cord blood CD34+ cells associated with selective inactivation of Lyn.
    Harashima A, Suzuki M, Okochi A, Yamamoto M, Matsuo Y, Motoda R, Yoshioka T, Orita K.
    Blood; 2002 Dec 15; 100(13):4440-5. PubMed ID: 12393728
    [Abstract] [Full Text] [Related]

  • 10. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
    Bouscary D, Pene F, Claessens YE, Muller O, Chrétien S, Fontenay-Roupie M, Gisselbrecht S, Mayeux P, Lacombe C.
    Blood; 2003 May 01; 101(9):3436-43. PubMed ID: 12506011
    [Abstract] [Full Text] [Related]

  • 11. Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor.
    Arcasoy MO, Jiang X.
    Br J Haematol; 2005 Jul 01; 130(1):121-9. PubMed ID: 15982354
    [Abstract] [Full Text] [Related]

  • 12. Liar, a novel Lyn-binding nuclear/cytoplasmic shuttling protein that influences erythropoietin-induced differentiation.
    Samuels AL, Klinken SP, Ingley E.
    Blood; 2009 Apr 16; 113(16):3845-56. PubMed ID: 19064729
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A, Arai K.
    Oncologist; 1996 Apr 16; 1(5):337-339. PubMed ID: 10388012
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Erythropoietin-driven signaling ameliorates the survival defect of DMT1-mutant erythroid progenitors and erythroblasts.
    Horvathova M, Kapralova K, Zidova Z, Dolezal D, Pospisilova D, Divoky V.
    Haematologica; 2012 Oct 16; 97(10):1480-8. PubMed ID: 22580996
    [Abstract] [Full Text] [Related]

  • 18. β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase.
    Su KH, Shyue SK, Kou YR, Ching LC, Chiang AN, Yu YB, Chen CY, Pan CC, Lee TS.
    J Cell Physiol; 2011 Dec 16; 226(12):3330-9. PubMed ID: 21321940
    [Abstract] [Full Text] [Related]

  • 19. The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells--signals emanating from the erythropoietin receptor.
    Klingmüller U.
    Eur J Biochem; 1997 Nov 01; 249(3):637-47. PubMed ID: 9395308
    [Abstract] [Full Text] [Related]

  • 20. Activated Fps/Fes tyrosine kinase regulates erythroid differentiation and survival.
    Sangrar W, Gao Y, Bates B, Zirngibl R, Greer PA.
    Exp Hematol; 2004 Oct 01; 32(10):935-45. PubMed ID: 15504549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.